Xin Cao

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Respiratory Syncytial Virus

Cross Sectional

Gestational Age

Top Venues

Human vaccines & immunotherapeutics

Merck & Co Inc

George Mason University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Merck & Co Inc Mar 24o 2016

United States

Associate statistician :: Late stage development-Vaccine

Education History

George Mason University Aug 25o 2011 - May 29o 2015

United States

PHD :: Statistics

Publications

Erin M Paradis, Oleg Tikhonov, Xin Cao, Susanna M Kharit, Aleksandr Fokin, Heather L Platt, Natalie Banniettis
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults. Human vaccines & immunotherapeutics (2021)
Erin M Paradis, Oleg Tikhonov, Xin Cao, Susanna M Kharit, Aleksandr Fokin, Heather L Platt, Frederick Wittke, Veronika Jotterand
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents. Human vaccines & immunotherapeutics (2021)
Antonios O Aliprantis, Christine A Shaw, Paul Griffin, Nicholas Farinola, Radha A Railkar, Xin Cao, Wen Liu, Jeffrey R Sachs, Christine J Swenson, Heather Lee, Kara S Cox, Daniel S Spellman, Colleen J Winstead, Igor Smolenov, Eseng Lai, Tal Zaks, Amy S Espeseth, Lori Panther
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Human vaccines & immunotherapeutics 17 (5) (2020)